Chemomab Therapeutics Ltd. - American Depository Shares, each representing twenty (20) ordinary shares, no par value (CMMB)

Historical Holders from Q1 2021 to Q1 2025

Symbol
CMMB on Nasdaq
CUSIP
16385C104
Type / Class
Equity / American Depository Shares, each representing twenty (20) ordinary shares, no par value
Shares outstanding
18.8M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
4.16M
Holdings value
$7.53M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
16
Number of buys
4
Number of sells
-10
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Chemomab Therapeutics Ltd. - American Depository Shares, each representing twenty (20) ordinary shares, no par value (CMMB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SPHERA FUNDS MANAGEMENT LTD. 4.78% $981K 900K Sphera Funds Management Ltd. Mar 31, 2025

Institutional Holders of Chemomab Therapeutics Ltd. - American Depository Shares, each representing twenty (20) ordinary shares, no par value (CMMB)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 34.9K $38K +$6.51K $1.09 2
2024 Q4 4.16M $7.53M -$700K $1.81 16
2024 Q3 4.55M $7.14M +$3.02M $1.57 15
2024 Q2 2.67M $2.44M +$15.8K $0.91 15
2024 Q1 2.66M $2.07M -$36.3K $0.78 14
2023 Q4 2.81M $1.43M +$108K $0.51 16
2023 Q3 2.53M $2.26M -$524 $0.90 11
2023 Q2 2.53M $3.33M -$562K $1.32 10
2023 Q1 2.89M $4.56M -$696K $1.59 12
2022 Q4 3.31M $10.6M +$240K $3.20 13
2022 Q3 3.25M $8.09M -$130K $2.49 13
2022 Q2 3.29M $12.2M -$117K $3.70 13
2022 Q1 3.31M $15.9M -$114K $4.80 14
2021 Q4 3.29M $22.7M +$311K $6.90 14
2021 Q3 3.24M $35.9M +$733K $11.08 13
2021 Q2 3.09M $58.7M +$1.76M $19.02 11
2021 Q1 2.88M $82.6M +$82.6M $28.74 10